Allergy diagnostic market to grow to $10.77B by 2030, driven by tech advances and rising allergy cases

The global allergy diagnostic market is projected to grow from $6.8 billion in 2025 to $10.77 billion by 2030, at a CAGR of 9.6%. This growth is fueled by technological innovations like multiplex immunoassays and molecular allergology, which improve test accuracy and efficiency. Rising allergy incidences due to urbanization, environmental changes, and lifestyle factors are increasing demand, especially in Asia Pacific and emerging markets. North America leads the market, supported by advanced healthcare infrastructure and key players such as Thermo Fisher Scientific and Siemens Healthineers driving innovation and market expansion.